Under what circumstances would you use pasireotide in the management of insulinoma-associated hypoglycemia?

Vega-Beyhart, et al., PMID 40165498

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

What is your approach to the use of GLP-1 agonists in older adults with diabetes with or at risk of sarcopenia?

Would you start a GLP-1 receptor agonist for the treatment of type 2 diabetes in patients with remote family history of medullary thyroid cancer without genetic testing?

Do you recommend that patients with type 2 diabetes who regularly drink artificially sweetened beverages continue their current consumption, gradually reduce their intake, or switch entirely to water in light of the SODAS trial?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.